The neutrophil to lymphocyte ratio is a prognostic biomarker of CD40 immunotherapy.
The Beatty Laboratory is part of the Perelman School of Medicine at the University of Pennsylvania.
The Beatty Laboratory is part of the Perelman School of Medicine at the University of Pennsylvania.
